Torti L - Search Results

1

Hokland P, Daar S, Khair W, Sheth S, Taher AT, Torti L, Hantaweepant C, Rund D. Hokland P, et al. Among authors: torti l. Br J Haematol. 2023 Apr;201(2):199-214. doi: 10.1111/bjh.18671. Epub 2023 Feb 17. Br J Haematol. 2023. PMID: 36799486 Review.

2

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma.

Cingolani A, Torti L, Pinnetti C, de Gaetano Donati K, Murri R, Tacconelli E, Larocca LM, Teofili L. Cingolani A, et al. Among authors: torti l. AIDS. 2010 Sep 24;24(15):2408-12. doi: 10.1097/QAD.0b013e32833db989. AIDS. 2010. PMID: 20671541

3

Essential thrombocythemia as underlying cause of malabsorption syndrome.

Teofili L, Torti L, Cina A, Gasbarrini A, Novi M, Leone G, Larocca LM. Teofili L, et al. Among authors: torti l. Ann Hematol. 2010 Oct;89(10):1067-8. doi: 10.1007/s00277-010-0924-2. Epub 2010 Feb 25. Ann Hematol. 2010. PMID: 20182878 Free article. No abstract available.

4

Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis.

Teofili L, Giona F, Martini M, Torti L, Cenci T, Foà R, Leone G, Larocca LM. Teofili L, et al. Among authors: torti l. J Clin Oncol. 2010 Jul 1;28(19):e317-8. doi: 10.1200/JCO.2010.29.0387. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516451 No abstract available.

5

Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and "novel agent" therapy.

Torti L, Pulini S, Morelli AM, Bacci F, Di Bartolomeo P. Torti L, et al. Int J Hematol. 2015 Oct;102(4):391-3. doi: 10.1007/s12185-015-1863-4. Epub 2015 Sep 10. Int J Hematol. 2015. PMID: 26358056 No abstract available.

6

Life beyond alpha-thalassaemia: We are moving forward.

Torti L. Torti L. Br J Haematol. 2022 Oct;199(1):11-13. doi: 10.1111/bjh.18362. Epub 2022 Aug 15. Br J Haematol. 2022. PMID: 35968718

7

Early COVID-19 treatment with Sotrovimab in high-risk Beta-thalassemia: Real-life case-series, state of the art and new perspectives.

Torti L. Torti L. Br J Haematol. 2023 Oct;203(2):e82-e86. doi: 10.1111/bjh.19011. Epub 2023 Aug 7. Br J Haematol. 2023. PMID: 37545354 No abstract available.

8

Epidemiological Surveillance of SARSCov2 in β-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges.

Torti L, Sorrentino F, Maffei L, De Fabritiis P, Abruzzese E. Torti L, et al. Mediterr J Hematol Infect Dis. 2023 Jan 1;15(1):e2023007. doi: 10.4084/MJHID.2023.007. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 36660359 Free PMC article. No abstract available.

9

Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects?

Torti L, Maffei L, Sorrentino F, De Fabritiis P, Miceli R, Abruzzese E. Torti L, et al. Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020052. doi: 10.4084/MJHID.2020.052. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 32670530 Free PMC article. No abstract available.

10

The mutant JAK2 allele burden in children with essential thrombocythemia.

Teofili L, Cenci T, Martini M, Capodimonti S, Torti L, Giona F, Amendola A, Randi ML, Putti MC, Scapin M, Leone G, Larocca LM. Teofili L, et al. Among authors: torti l. Br J Haematol. 2009 May;145(3):430-2. doi: 10.1111/j.1365-2141.2009.07591.x. Epub 2009 Feb 4. Br J Haematol. 2009. PMID: 19208099 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page